Back to Search
Start Over
FDA allows controversial bowel drug back on to market.
- Source :
-
Lancet . 6/15/2002, Vol. 359 Issue 9323, p2095. 1/2p. - Publication Year :
- 2002
-
Abstract
- Reports that the U.S. Food and Drug Administration has decided to reapprove the use of alosetron hydrochloride to treat irritable bowel syndrome. Controversy about the drug, which was pulled from the market after reports of dangerous side effects; Restrictions on the use of the drug; Response of the drug's manufacturer, GlaxoSmithKline.
- Subjects :
- *IRRITABLE colon treatment
*DRUG side effects
*COLON diseases
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 01406736
- Volume :
- 359
- Issue :
- 9323
- Database :
- Academic Search Index
- Journal :
- Lancet
- Publication Type :
- Academic Journal
- Accession number :
- 6813438
- Full Text :
- https://doi.org/10.1016/S0140-6736(02)08963-8